世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000032588

ヨーロッパの腫瘍マーカー診断検査市場評価(2022年〜2026年):ビジネスチャンス - フランス、ドイツ、イタリア、スペイン、イギリス - 癌遺伝子、バイオマーカー、GF、CSF、ホルモン、ステイン、リンフォカイン - 競合企業のシェアと戦略、数量と売上セグメントの予測、最新技術と機器のパイプライン、サプライヤーの新たなビジネスチャンス

VPGMarketResearch

2022-2026 Europe Tumor Markers Diagnostic Testing Market Assessment: Business Opportunities--France, Germany, Italy, Spain, UK--Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines--Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

発刊日 2022/07/11

言語英語

体裁PDF

ライセンス/価格

0000032588

Local PDF
Global PDF
DataPack

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。電子媒体での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、今後5年間にヨーロッパの癌診断市場に出現する主なビジネスチャンスについて調査したものです。本レポートは、ヨーロッパの主要国の動向を調査し、現在および将来のアッセイの検討、新しい診断技術の潜在的な用途の分析、主要な腫瘍マーカーの国別および市場セグメント別の売上の予測、主要企業や市場参入の可能性を提供し、サプライヤーにとっての特定のビジネス機会を特定しています。

本レポートはセクションごとに提供され、特定の情報ニーズや予算に合わせてカスタマイズすることが可能です。

論理的根拠

癌診断市場は、研究者が腫瘍診断と治療における主要な技術的ブレークスルーに近づき、新しい特異的抗原を発見し、疾患の遺伝子基盤の謎を解き明かすことで、爆発的に拡大しようとしています。今後5年間、世界の癌診断市場は、刺激的でダイナミック、そして急速に拡大する分野として期待されています。予想される技術の飛躍的進歩により、遺伝的素因の決定、特定の腫瘍の検出、癌治療に対する生物学的反応のモニタリングなど、数多くの機会が創出されることでしょう。老年人口の増加は、悪性腫瘍アッセイに対する需要の増加と世界的な市場の急速な拡大をさらに加速させるでしょう。

調査範囲

  • 調査国
    ➣ フランス
    ➣ ドイツ
    ➣ イタリア
    ➣ スペイン
    ➣ イギリス
  • ヨーロッパ市場の概要
    ➣ 5年間の国別の検査件数および売上予測
    ➣ 国別の市場力学、構造、規模、成長、主要サプライヤーのレビューを含む包括的な市場セグメンテーション分析
    ➣ 癌診断検査を実施するラボの国別の推定数
    ➣ 癌の統計、病因および最近の開発
  • ビジネスチャンスおよび戦略的提案
    ➣ 今後5年間で市場に大きなアピールをもたらす可能性のある特定の新製品開発の機会
    ➣ 新製品の設計基準
    ➣ 代替市場浸透戦略
    ➣ 潜在的な市場参入障壁とリスク
  • 200を超える現在および新たな癌診断検査
    ➣ 生化学的マーカー
    ➣ 癌遺伝子
    ➣ 成長因子
    ➣ ホルモン
    ➣ コロニー刺激因子
    ➣ リンフォカイン
    ➣ 免疫組織化学染色
    ➣ ACTH、AFP、ベータ2ミクログロブリン、CA 15-3 / 27.29、CA 19-9、CA 125、カルシトニン、カテプシン、CEA、クロモグラニン、結腸特異的抗原、サイトケラチン、エストロゲン受容体、フェリチン、ガストリン、HCG、インスリン、 インターフェロン、インターロイキン、リンパ球サブタイピング、ニューロン特異的エノラーゼ、核、潜血、腫瘍遺伝子、膵臓癌胎児性抗原、パップスミア、副甲状腺ホルモン、プロゲステロン受容体、前立腺酸ホスファターゼ、前立腺特異的抗原、S-100タンパク質、セロトニン、シアル酸、 扁平上皮癌Ag、TDT、チミジンキナーゼ、サイログロブリン、組織ポリペプチド抗原など
  • サプライヤーのシェア、売上、数量の予測
    ➣ 主要な癌診断製品サプライヤーの個別検査別および国別の売上と市場シェア
    ➣ 主要な腫瘍マーカーの5年間の以下の市場セグメント別の検査件数と売上の予測
      ◇ 病院
      ◇ 商業/民間研究所
      ◇ 診療所/グループ診療所
      ◇ 癌クリニック
      ◇ 外来ケアセンター
  • 機器のレビュー
    ➣ 癌検査に使用される主要な分子診断・免疫診断分析装置の動作特性、特徴、販売価格などの分析
  • 技術の評価
    ➣ 最新の分子診断法、バイオチップ/マイクロアレイ、バイオセンサー、モノクローナル抗体、イムノアッセイ、染色体分析、IT、人工知能、フローサイトメトリー、およびその他の技術の評価と、癌診断検査の潜在的なアプリケーション
    ➣ CT、MRI、NMR、PET、フォトニクス分光法などの競合/補完技術のレビュー
    ➣ 新しい癌診断検査や検出技術を開発している企業、大学、研究所の広範囲なリスト
  • 競争戦略
    ➣ 革新的な癌診断技術や製品を開発している主要サプライヤーや新興企業の戦略的評価(売上、製品ポートフォリオ、マーケティング戦略、提携関係、研究開発中の新製品など)
  • 調査企業
    ➣ Abbott
    ➣ Affymetrix
    ➣ Beckman Coulter/Danaher/Cepheid
    ➣ Becton Dickinson
    ➣ bioMerieux
    ➣ Bio-Rad
    ➣ DiaSorin
    ➣ 栄研化学(Eiken Chemical)
    ➣ Elitech Group
    ➣ Enzo Biochem
    ➣ 富士フイルム和光純薬(Fujifilm Wako)
    ➣ 富士レビオ(Fujirebio)
    ➣ Grifols
    ➣ Hologic
    ➣ Leica Biosystems
    ➣ Ortho-Clinical Diagnostics
    ➣ PerkinElmer
    ➣ Qiagen
    ➣ Roche
    ➣ Siemens Healthineers
    ➣ タカラバイオ(Takara Bio)
    ➣ Thermo Fisher

レポート詳細

目次

Table of Contents

I. Introduction

II. Worldwide Market Overview

III. Major Product Development Opportunities
A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products

IV. Design Criteria for Decentralized Testing Products

V. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies

VI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VII. Worldwide Market and Technology Overview
A. Cancer Statistics and Etiology
 1. Breast Cancer
 2. Lung Cancer
 3. Colon and Rectum Cancer
 4. Prostate Cancer
 5. Stomach Cancer
 6. Leukemia
 7. Lymphoma
 8. Oral Cancer
 9. Skin Cancer
 10. Uterine Cancer
 11. Ovarian Cancer
 12. Bladder Cancer
B. Major Current and Emerging Cancer Diagnostic Tests
 1. Introduction
 2. Tumor Marker Classification
 3. ACTH
 4. Alpha-Fetoprotein (AFP)
 5. Beta-2 Microglobulin
 6. CA 15-3/27.29
 7. CA 19-9
 8. CA-125
 9. Calcitonin
 10. Carcinoembrionic Antigen (CEA)
 11. Estrogen and Progesterone Receptors
 12. Ferritin
 13. Gastrin
 14. Human Chorionic Gonadotropin (HCG)
 15. Insulin
 16. NSE
 17. Occult Blood
 18. PAP Smear/HPV
 19. Prostatic Acid Phosphatase (PAP)
 20. Prostate-Specific Antigen (PSA)
 21. Squamous Cell Carcinoma Antigen (SCC)
 22. T and B Lymphocytes
 23. TdT
 24. Thyroglobulin
 25. Tissue Polypeptide Antigen (TPA)
 26. Biochemical Tumor Markers
 27. Oncogenes
   - Abl/abl-bcr
   - AIB1
   - BCL-2
   - BRCA1
   - CD44
   - C-fos
   - C-myb
   - C-myc
   - CYP-17
   - Erb-B
   - HPC1
   - N-myc
   - P40
   - P51
   - P53
   - PIK3CA
   - PTI-1
   - Ras
   - Reg
   - Sis
   - Src and others
 28. Polypeptide Growth Factors
   - Basic Fibroblast Growth Factor
   - Beta-TGF
   - Cachectin (TNT)
   - Calmodulin
   - ECFR
   - Nerve Growth Factor (NGF)
   - Epidermal Growth Factor (EGF)
   - Ornithine Decarboxylase
   - Transferrin
   - Transforming Growth Factor-Alpha
 29. Ectopic Hormones
 30. Colony Stimulating Factors
 31. Lymphokines
   - Alpha-Interferon
   - B Cell Growth Factors
   - B Cell Growth Factor (BCGF)
   - Gamma-Interferon
   - Interleukin-1 (IL-1)
   - Macrophage Activating Factor
 32. Immunohistochemical Stains
 33. Emerging Tumor Markers
   - N-Acetylglucosamine
   - Actin
   - Alpha-Actin
   - Antineuronal Antibodies
   - 7B2
   - B72.3
   - Bax
   - BCD-F9
   - BLCA-4
   - Blood Group Antigens A,B,H
   - CA 50
   - CA 72-4/TAG-72
   - CA 195
   - CA-242
   - CA-549
   - CAM 26
   - CAR-3
   - Cathepsin-D
   - Chromogranin A and B
   - Cluster 1 Antigen
   - Cluster-5/5A Antigen
   - CTA
   - CU18
   - DR-70
   - DU-PAN-2
   - Endometrial Bleeding Associated Factor
   - Endostatin
   - Epithelial Membrane Antigen
   - Feulgen Hydrolysis
   - Fibronectin
   - FSH
   - (1->3)-L-fucosyltransferase
   - Gastrin-Releasing Peptide (GRP)
   - GDCFP-15
   - Glucagon
   - Glycoamines
   - H23
   - Her-2
   - Human Carcinoma Antigen
   - HPA
   - HSP27
   - Intermediate Filaments
   - Cytokeratins/CK18/Cyfra 21-1
   - Desmin
   - Gliofibrillary Acid Protein
   - Neurofilaments
   - Vimentin
   - KA 93
   - Kinases
   - KP16D3
   - LAI
   - Leukocyte Common Antigen
   - Lewis Antigens
   - Lysophosphatidic Acid (LPA)
   - Ma 695/Ma 552
   - MABDF3
   - MAG
   - ME1
   - Minactivin
   - MN/CA9
   - MSA
   - Mucin Cancer Antigen (MCA)
   - Multiple Tumor Suppressor 1
   - Myosin
   - NEA-130
   - NMP22
   - OA-519
   - Opioid Peptides
   - P-glycoprotein
   - Pancreatic Oncofetal Antigen (POA)
   - Placental Lactogen
   - PR92
   - Proliferative Index, Ki-67
   - Px
   - RB Inactivation/Deletion
   - Ret
   - SCCL 175
   - Selectin
   - Sialic Acid
   - Sialyl SSEA-1/SLX
   - SN10
   - Somatostatin
   - TA-90
   - TABA
   - Tachykinin
   - TAG 12
   - TPS
   - Troponin
   - Tubulin
   - VCAM
   - VEGF
   - Villen and others
C. Cancer Diagnostic Testing Instrumentation Review and Market Needs
D. Current and Emerging Cancer Diagnostic Technologies
 1. Monoclonal and Polyclonal Antibodies
 2. Immunoassays
 3. Molecular Diagnostics
 4. Chromosome Analysis
  a. Chronic Myelogenous Leukemia (CML)
  b. Acute Myeloid Leukemia (AML)
  c. Acute Lymphoblastic Leukemia (ALL)
  d. Malignant Lymphomas Lymphoid Malignancies
  e. Chronic Lymphocytic Leukemia (CLL)
  f. Solid Cancers
  g. Chromosomal Translocation and Oncogenes
 5. Artificial Intelligence
 6. Flow Cytometry
 7. Two Dimensional Gel Electrophoresis (2-DGE)
 8. Biosensors
 9. Competing/Complementing Technologies
E. Personal Testing

VIII. France Cancer Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier
Sales and Market Shares by Test

IX. Germany Cancer Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier
Sales and Market Shares by Test

X. Italy Cancer Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier
Sales and Market Shares by Test

XI. Spain Cancer Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier
Sales and Market Shares by Test

XII. U.K. Cancer Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier
Sales and Market Shares by Test

XIII. Competitive Profiles
The report provides strategic assessments of over 30 leading cancer diagnostics market players and start-up companies with innovative technologies and products, including:
   - Abbott
   - Affymetrix
   - Beckman Coulter/Danaher
   - Becton Dickinson
   - bioMerieux
   - Bio-Rad
   - Cepheid
   - DiaSorin
   - Eiken Chemical
   - Elitech Group
   - Enzo Biochem
   - Fujirebio
   - Grifols
   - Hologic
   - Leica Biosystems
   - Ortho-Clinical Diagnostics
   - PerkinElmer
   - Qiagen
   - Roche
   - Siemens Healthineers
   - Takara Bio
   - Thermo Fisher
   - Wako and others.

List of Tables
Tumor Marker Classification
Major Companies Developing or Marketing
ACTH Tests
Major Companies Developing or Marketing
AFP Tests
Major Companies Developing or Marketing
Beta-2 Microglobulin Tests
Major Companies Developing or Marketing
CA 15-3/27.29 Tests
Major Companies Developing or Marketing
CA 19-9 Tests
Major Companies Developing or Marketing
CA 125 Tests
Major Companies Developing or Marketing
Calcitonin Tests
Major Companies Developing or Marketing
CEA Tests
Major Companies Developing or Marketing
Estrogen Receptor Tests
Major Companies Developing or Marketing
Progesterone Receptor Tests
Major Companies Developing or Marketing
Ferritin Tests
Major Companies Developing or Marketing
Gastrin Tests
Major Companies Developing or Marketing
HCG Tests
Major Companies Developing or Marketing
Insulin Tests
Major Companies Developing or Marketing
NSE Tests
Major Companies Developing or Marketing
Occult Blood Tests
Major Companies Developing or Marketing
PAP Smear/HPV Tests
Major Companies Developing or Marketing
PAP Tests
Major Companies Developing or Marketing
PSA Tests
Major Companies Developing or Marketing
Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications
In Cancer Diagnosis
Oncogenes Potential Applications
In Cancer Diagnosis
Major Companies Developing or Marketing
Oncogene Tests
Growth Factors Potential Applications
In Cancer Diagnosis
Colony Stimulating Factors Potential
Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis
Immunohistochemical Stains Potential
Applications in Cancer Diagnosis
Executive Summary Table: France, Total Cancer
Diagnostic Test Volume and Sales Forecast by Market Segment
France, Estimated Cancer Death Rates
Per 100,000 Population
France, Laboratories Performing Tumor
Marker Tests by Market Segment
France, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
France, Commercial/Private Laboratories
Performing Tumor Markers by Annual Test Volume
France, Total Tumor Marker Test Volume
Forecast by Market Segment
France, All Market Segments Major Tumor
Marker Test Volume Forecast
France, Hospital Laboratories Major Tumor
Marker Test Volume Forecast by Test
France, Commercial/Private Laboratories
Marker Test Volume Forecast
France, Total Tumor Marker Sales Major Tumor
Forecast by Market Segment
France, All Market Segments Major Tumor
Marker Sales Forecast by Test
France, Hospital Laboratories Major Tumor
Marker Sales Forecast by Test
France, Commercial/Private Laboratories Cancer
Diagnostics Market Forecast by Test
France, ACTH Test Volume and Diagnostics Sales
Forecast by Market Segment
France, AFP Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
France, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
France, CA 19-9 Test Volume and Diagnostics
Sales Forecast by Market
France, CA-125 Test Volume and Diagnostics
Sales Forecast by Market Segment
France, Calcitonin Test Volume and Diagnostics
Sales Forecast by Market Segment
France, Cathepsin Test Volume and Diagnostics
Sales Forecast by Market Segment
France, CEA Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Colon-Specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
France, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
France, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market
Segment
France, Ferritin Test Volume and Diagnostics Sales Forecast by Market
Segment
France, Gastrin Test Volume and Diagnostics Sales Forecast by Market
Segment
France, HCG Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Insulin Test Volume and Diagnostics Sales Forecast by Market
Segment
France, Interferons Test Volume and Diagnostics Sales Forecast by Market
Segment
France, Interleukins Test Volume and Diagnostics Sales Forecast by Market
Segment
France, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market
Segment
France, NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
France, Nucleolar Test Volume and Diagnostics
Sales Forecast by Market Segment
France, Occult Blood Test Volume and Diagnostics Sales Forecast by Market
Segment
France, Oncogenes Test Volume and Diagnostics Sales Forecast by Market
Segment
France, Pancreatic Oncofetal Antigen
Test Volume and Diagnostics Sales
Forecast by Market Segment
France, PAP Smear Test Volume and Diagnostics Sales Forecast by Market
Segment
France, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market
Segment
France, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market
Segment
France, PAP Test Volume and Diagnostics Sales
Forecast by Market Segment
France, PSA Test Volume and Diagnostics Sales
Forecast by Market Segment
France, S-100 Protein Test Volume and Sales
Diagnostics Sales Forecast by Market
Segment
France, Serotonin Test Volume and Diagnostics Sales Forecast by Market
Segment
France, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market
Segment
France, Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics Sales
Forecast by Market Segment
France, TDT Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by
Market Segment
France, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market
Segment
France, TPA Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Total Tumor Marker Sales by Major Suppliers
France, AFP Testing Market Diagnostics
Sales by Major Supplier
France, CA 15-3 Testing Market Diagnostics
Sales by Major Supplier
France, CA 19-9 Testing Market Diagnostics
Sales by Major Supplier
France, CA 125 Testing Market Diagnostics
Sales by Major Supplier
France, CEA Testing Market Diagnostics
Sales by Major Supplier
France, NSE Testing Market Diagnostics
Sales by Major Supplier
France, PAP Testing Market Diagnostics
Sales by Major Supplier
France, PSA Testing Market Diagnostics
Sales by Major Supplier
Executive Summary Table: Germany, Total
Tumor Marker Test Volume and Sales Forecast by Market Segment
Germany, Estimated Cancer Death Rates
Per 100,000 Population
Germany, Laboratories Performing Tumor
Marker Tests by Market Segment
Germany, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
Germany, Commercial/Private Laboratories
Performing Tumor Markers by Annual
Test Volume
Germany, Total Tumor Marker Test Volume
Forecast by Market Segment
Germany, All Market Segments, Major Tumor
Marker Test Volume Forecast
Germany, Hospital Laboratories, Major
Tumor Marker Test Volume Forecast by Test
Germany, Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
Germany, Physician Offices/Group
Practices Major Tumor Marker
Test Volume Forecast
Germany, Total Tumor Marker Sales
Forecast by Market Segment
Germany, All Market Segments Major Tumor
Marker Sales Forecast by Test
Germany, Hospital Laboratories, Major Tumor
Marker Sales Forecast by Test
Germany, Commercial/Private Laboratories
Major Tumor Marker Sales Forecast by Test
Germany, Physician Offices/Group Practices
Major Tumor Marker Sales Forecast by Test
Germany, ACTH Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, AFP Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, CA-15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, CA-19 Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, CA 125 Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Calcitonin Test Volume and Diagnostic Sales Forecast by Market Segment
Germany, Cathepsin Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, CEA Test Volume and Diagnostics Sales
Forecast by Market Segment
Germany, Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Colon-Specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Ferritin Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, HCG, Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Pancreatic Oncofetal Antigen
Test Volume and Diagnostics Sales
Forecast by Market Segment
Germany, Pap Smear Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, PAP Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, PSA Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, TDT Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, TPA Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Total Tumor Marker Sales by Major Supplier
Germany, AFP Testing Market Diagnostics
Sales by Major Supplier
Germany CA 15-3/27.29 Testing Market
Diagnostics Sales by Major Supplier
Germany CA 19-9 Testing Market Diagnostics
Sales by Major Supplier
Germany, CA 125 Testing Market Diagnostics
Sales by Major Supplier
Germany, CEA Testing Market Diagnostics
Sales by Major Supplier
Germany, PSA Testing Market Diagnostics
Sales by Major Supplier
Executive Summary Table: Italy, Total Tumor
Marker Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Estimated Cancer Death Rates
Per 100,000 Population
Italy, Laboratories Performing Tumor
Marker Tests by Market Segment
Italy, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
Italy, Commercial/Private Laboratories
Performing Tumor Markers by Annual
Test Volume
Italy, Total Tumor Marker Test Volume
Forecast by Market Segment
Italy, All Market Segments Major Cancer
Diagnostic Test Volume Forecast
Italy, Hospital Laboratories Major Tumor
Marker Test Volume Forecast
Italy, Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
Italy, Total Tumor Marker Test Market
Forecast by Market Segment
Italy, All Market Segments Major Tumor
Marker Sales Forecast by Test
Italy, Hospital Laboratories Major
Tumor Marker Forecast by Test
Italy, Commercial/Private Laboratories
Major Tumor Marker Sales Forecast by Test
Italy, ACTH Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, AFP Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment

Italy, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, CA-19-9 Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, CA 125 Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Calcitonin Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, CEA Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Colon Specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Ferritin Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, HCG Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market
Segment
Italy, NSE Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Occult Blood Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Oncogenes Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Pancreatic Oncofetal Antigen Test
Volume and Diagnostics Sales Forecast by Market Segment
Italy, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, PAP Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, PSA Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, S-100 Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Squamous Cell Carcinoma Antigen Test
Volume and Diagnostics Sales Forecast by Market Segment
Italy, TDT Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, TPA Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Total Tumor Markers
Sales by Major Suppliers
Italy, AFP Testing Market Diagnostics
Sales by Major Supplier
Italy, CEA Testing Market Diagnostics
Sales by Major Supplier
Italy, PSA Testing Market Diagnostics
Sales by Major Supplier
Executive Summary Table: Spain, Total
Tumor Marker Test Volume and Sales
Forecast by Market Segment
Spain, Estimated Cancer Death Rates
Per 100,000 Population
Spain, Laboratories Performing Tumor
Marker Tests by Market Segment
Spain, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
Spain, Commercial/Private Laboratories
Performing Tumor Markers by
Annual Test Volume
Spain, Total Tumor Marker Test Volume
Forecast by Market Segment
Spain, All Market Segment Major Cancer
Diagnostic Test Volume Forecast
Spain, Hospital Laboratories Major Cancer
Diagnostic Test Volume Forecast by Test
Spain, Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
Spain, Total Tumor Marker Sales
Forecast by Market Segment
Spain, All Market Segments Major Tumor
Marker Sales Forecast by Test
Spain, Hospital Laboratories Major Tumor
Marker Sales Forecast by Test
Spain, Commercial/Private Laboratories Major
Tumor Marker Sales Forecast by Test
Spain, AFP Test Volume and Diagnostics Sales
Forecast by Market Segment
Spain, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, CA 15-3 Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, CA 19-9 Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, CA-125 Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Calcitonin Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, CEA Test Volume and Diagnostics Sales
Forecast by Market Segment
Spain, Colon-Specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Ferritin Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, HCG Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Lymphocyte Subtyping
Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Occult Blood Test Volume and Diagnostics Sales Forecast by Market
Segment
Spain, Oncogenes Test Volume and Diagnostics Sales Forecast by Market
Segment
Spain, Pancreatic Oncofetal Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, PAP Smear Test Volume and Diagnostics Sales Forecast by Market
Segment
Spain, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market
Segment
Spain, Progesterone Receptor
Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, PAP Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, PSA Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, S-100 Protein Test Volume and Diagnostics Sales Forecast by Market
Segment
Spain, Serotonin Test Volume and Diagnostics Sales Forecast by Market
Segment
Spain, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market
Segment
Spain, Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, TDT Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Thymidine Kinase
Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Thyroglobulin
Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, TPA Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Total Tumor Marker Sales by Major Suppliers
Spain, AFP Testing Market Diagnostics
Sales by Major Supplier
Spain, CA 15-3/27.29 Testing Market
Diagnostics Sales by Major Supplier
Spain, 19-9 Testing Market Diagnostics
Sales by Major Supplier
Spain, CA 125 Testing Market Diagnostics
Sales by Major Supplier
Spain, CEA Testing Market Diagnostics
Sales by Major Supplier
Spain, PSA Testing Market Diagnostics
Sales by Major Supplier
Executive Summary Table: U.K., Total
Tumor Marker Test Volume and Sales
Forecast by Market Segment
U.K., Estimated Cancer Death Rates
Per 100,000 Population
U.K., Laboratories Performing Tumor
Marker Tests by Market Segment
U.K., Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
U.K., Commercial/Private Laboratories
Performing Tumor Marker Tests by
Annual Test Volume
U.K., Total Tumor Marker Testing Volume
Forecast by Market Segment
U.K., All Market Segments Major
Tumor Marker Test Volume Forecast
U.K., Hospital Laboratories Major
Tumor Marker Test Volume Forecast by Test
U.K., Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
U.K., Total Tumor Marker Sales
Forecast by Market Segment
U.K., All Market Segments Major
Tumor Marker Sales Forecast by Test
U.K., Hospital Laboratories Major
Tumor Marker Sales Forecast by Test
U.K., Commercial/Private Laboratories
Major Tumor Marker Sales Forecast by Test
U.K., ACTH Test Volume and Diagnostics Sales
Forecast by Market Segment
U.K., AFP Test Volume and Diagnostics Sales
Forecast by Market Segment
U.K., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., CA 19-9 Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., CA-125 Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Calcitonin Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K., CEA Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Chromogranin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Colon-Specific Antigen Test Volume and Diagnostics Sales by Market
Segment
U.K., Cytokeratins Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K., Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K., Ferritin Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K., Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., HCG Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K., NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Occult Blood Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K., Oncogenes Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K., Pancreatic Oncofetal Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., PAP Smear Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Parathyroid Hormone
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Progesterone Receptor
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., PAP Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., PSA Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Serotonin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., TDT Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Thymidine Kinase
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Thyroglobulin
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., TPA Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Total Tumor Marker Sales and Market Shares Forecast
U.K., CEA Testing Market Diagnostics
Sales by Major Supplier
U.K., PSA Testing Market Diagnostics
Sales by Major Supplier

この商品のレポートナンバー

0000032588

TOP